Literature DB >> 22085125

Complete resolution of urinary bladder condyloma acuminatum following definitive chemoradiotherapy for anal cancer.

Rohen White1, Scott Donnellan, Trevor Leong.   

Abstract

UNLABELLED: What's known on the subject? and What does the study add? Condyloma acuminatum of the bladder is a rare affliction and as such its ideal management is unknown. This manuscript describes curative treatment of severe disease with external beam radiotherapy concurrent with low dose chemotherapy, an approach which has not previously been utilised.
OBJECTIVES: • To report the first occurrence of complete and sustained resolution of symptomatic condyloma acuminatum of the bladder with chemoradiotherapy. • To describe the relevant patient details, imaging findings and chemoradiation treatment. PATIENT AND
METHOD: • A 54-year-old female with extensive condyloma acuminatum of the bladder and a long history of human papilloma virus related anogenital disease was diagnosed with anal squamous cell carcinoma. • Cystectomy for the bladder disease was delayed whilst chemoradiotherapy was administered for the anal cancer.
RESULTS: • There was complete resolution of bladder disease at follow-up which has negated the need for cystectomy with its associated morbidity. • Condyloma acuminatum has not recurred in 4 years of follow-up.
CONCLUSION: • This is the first published report to our knowledge of the successful treatment of condyloma acuminatum of the bladder with chemoradiotherapy. • The individual contributions of radiotherapy vs chemotherapy cannot be discerned.
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2011        PMID: 22085125     DOI: 10.1111/j.1464-410X.2011.10685.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  1 in total

1.  Intravesical human papillomavirus (IHPV) infection-endoscopic resection.

Authors:  Silvio Henrique Maia Almeida; Marco Aurelio Cruciol Rodrigues; Daniele Mathiel; Susana Fonseca Alves
Journal:  Int Braz J Urol       Date:  2016 Mar-Apr       Impact factor: 1.541

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.